Seven steps to the effective treatment of osteoporosis in your practice

Contemporary Ob-Gyn

Volumn 43, Issue 2, 1998, Pages 30-50

  Barbieri, Robert L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347623729     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Consensus Development Conference. Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94:646-650.
2. Riggs BL, Wahner HW, Seeman E, et al. Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest. 1982;70:716-723.
3. Mostov K, Werb Z. Journey across the osteoclast. Science. 1997;276:219-220.
4. Cummings SR, Kelsey JL, Nevitt MC, et al. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985;7:178-208.
5. World Health Organization 1994. Assessment of fracture risks and its application to screening for post-menopausal osteoporosis. Technical Report Series. WHO Geneva
6. Kanis JA, Melton LJ, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137-1141.
7. Jergas M, Genant HK. Current methods and recent advances in the diagnosis of osteoporosis. Arthritis Rheum. 1993;36:1649-1662.
8. Wasnich RD, Ross PD, Heilbrun LK, et al. Prediction of postmenopausal fracture risk with use of bone mineral measurements. Am J Obstet Gynecol. 1985;153:745-751.
9. Melton LJ, Atkinson EJ, O'Fallon WM, et al. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Mineral Res. 1993;8:1227-1234.
10. Compston JE, Cooper C, Kanis JA. Bone density in clinical practice. BMJ. 1995;310:1507-1015.
11. Breslau NA. Calcium, estrogen, and progestin in the treatment of osteoporosis. Rheum Dis Clin North Amer. 1994;20:691-716.
12. Rosen CJ, Chestnut CH, Mallinak NJS. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab. 1997;82:1904-1910.
13. Lindsay R, Tohme JF. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol. 1990;76:290-295.
14. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985;102:319-324.
15. Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 1992;117:1-9.
16. Heaney RP. Calcium supplements: practical considerations. Osteoporosis Int. 1991;1:65-71.
17. Chapuy MC, Arlot MR, Delmas PD, et al. Effect of calcium and cholecalciferol treatment for 3 years on hip fractures in elderly women. BMJ. 1994;309:1081-1082.
18. Barrett-Connor E, Bush RL. Estrogen and coronary heart disease in women. JAMA. 1995;273:199-208.
19. Mizunuma H, Okano H, Soda M, et al. Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study. Maturitas. 1997;27:69-76.
20. Naessen T, Berglund L, Ulmsten U. Bone loss in elderly women prevented by ultra low doses of parenteral 17 beta-estradiol. Am J Obstet Gynecol. 1997;177:115-119.
21. Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate phase II osteoporosis treatment study group. N Engl J Med. 1995;333:1437-1443.
22. Reginster JY. Calcitonin for prevention and treatment of osteoporosis. Am J Med. 1993;95(suppl 5A):44S-47S.
23. Overgaard K, Hansen MA, Jensen SB, et al. Effect of salcaltonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ. 1992;305:556-561.
24. Rico H, Hernandez ER, Revma M, et al. Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome. Bone Miner. 1992;16:131-138.
25. Bjarnason NH, Bjarnason K, Haarbo J, et al. Tibolone: prevention of bone loss in late postmenopausal women. J Clin Endocrinol Metab. 1996;81:2419-2422.
26. Crona N, Silverstolpe G, Samsioe G. A double-blind crossover study on the effects of ORG OD14 compared to estradiol valerate and placebo on lipid and carbohydrate metabolism in oophorectomized women. Acta Endocrinol. 1983;102:451-455.